Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice.
Yoo Min HanJaemoon KohJee Hyun KimJooyoung LeeJong-Pil ImJoo Sung KimPublished in: Gut and liver (2021)
Astragalin exerted an anti-inflammatory effect through NF-κB pathway inhibition and attenuated murine colitis. Astragalin is thus a potential therapeutic agent for IBD.